Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

China Traditional Chinese Medicine Holdings Co. Limited CHIZF

Full chart Compare
Set alert

Price alert · CHIZF

All alert types
0.16 USD 0.00 (+0.00%)

At closeNov 3, 2026, 4:00 PM EST

0.2734 Day range 0.2734
0.1631 52-week range 0.2734
YTD
-40.34%
1 year
-40.34%

Financial health

Altman Z-Score

1.60 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B3 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 5

Valuation

P/E -28.2×
FY 2016: 14.8×FY 2017: 11.8×FY 2018: 10.8×FY 2019: 10.2×FY 2020: 9.3×FY 2021: 7.5×FY 2022: 22.5×FY 2023: 11.7×FY 2024: 229×FY 2025: -28.2×
FY 2016 5y median 11.7× FY 2025
P/S 0.7×
FY 2016: 2.2×FY 2017: 1.6×FY 2018: 1.4×FY 2019: 1.2×FY 2020: 1.0×FY 2021: 0.8×FY 2022: 1.2×FY 2023: 0.8×FY 2024: 0.7×FY 2025: 0.7×
FY 2016 5y median 0.8× FY 2025
P/B 0.5×
FY 2016: 1.3×FY 2017: 1.1×FY 2018: 1.0×FY 2019: 1.0×FY 2020: 0.9×FY 2021: 0.7×FY 2022: 0.8×FY 2023: 0.7×FY 2024: 0.6×FY 2025: 0.5×
FY 2016 5y median 0.7× FY 2025
P/FCF 4.9×
FY 2016: 11.7×FY 2017: 22.3×FY 2018: -216×FY 2019: 40.0×FY 2020: -15.1×FY 2021: -177×FY 2022: 30.1×FY 2023: 22.6×FY 2024: 6.0×FY 2025: 4.9×
FY 2016 5y median 6.0× FY 2025
EV/EBITDA 5.5×
FY 2016: 9.5×FY 2017: 6.5×FY 2018: 5.9×FY 2019: 5.5×FY 2020: 5.5×FY 2021: 4.6×FY 2022: 8.8×FY 2023: 6.8×FY 2024: 8.2×FY 2025: 5.5×
FY 2016 5y median 6.8× FY 2025
EV/Sales 0.5×
FY 2016: 2.5×FY 2017: 1.7×FY 2018: 1.4×FY 2019: 1.2×FY 2020: 1.2×FY 2021: 0.9×FY 2022: 1.3×FY 2023: 1.0×FY 2024: 0.8×FY 2025: 0.5×
FY 2016 5y median 0.9× FY 2025
FCF Yield 20.3%
FY 2016: 8.5%FY 2017: 4.5%FY 2018: -0.5%FY 2019: 2.5%FY 2020: -6.6%FY 2021: -0.6%FY 2022: 3.3%FY 2023: 4.4%FY 2024: 16.8%FY 2025: 20.3%
FY 2016 5y median 4.4% FY 2025

Profitability

Gross Margin 48.1%
FY 2016: 58.0%FY 2017: 55.8%FY 2018: 55.0%FY 2019: 59.9%FY 2020: 61.6%FY 2021: 62.1%FY 2022: 50.3%FY 2023: 51.2%FY 2024: 47.6%FY 2025: 48.1%
FY 2016 5y median 50.3% FY 2025
Operating Margin 4.2%
FY 2016: 22.0%FY 2017: 21.4%FY 2018: 19.1%FY 2019: 17.2%FY 2020: 16.8%FY 2021: 14.4%FY 2022: 7.4%FY 2023: 7.9%FY 2024: 2.0%FY 2025: 4.2%
FY 2016 5y median 7.4% FY 2025
Net Margin -2.3%
FY 2016: 14.8%FY 2017: 14.0%FY 2018: 12.8%FY 2019: 11.1%FY 2020: 11.2%FY 2021: 10.1%FY 2022: 5.3%FY 2023: 7.1%FY 2024: 0.3%FY 2025: -2.3%
FY 2016 5y median 5.3% FY 2025
ROE -1.7%
FY 2016: 8.3%FY 2017: 9.4%FY 2018: 9.3%FY 2019: 9.6%FY 2020: 9.2%FY 2021: 9.8%FY 2022: 3.8%FY 2023: 6.1%FY 2024: 0.3%FY 2025: -1.7%
FY 2016 5y median 3.8% FY 2025
ROIC 2.3%
FY 2016: 6.5%FY 2017: 7.2%FY 2018: 7.1%FY 2019: 7.5%FY 2020: 7.4%FY 2021: 7.8%FY 2022: 3.0%FY 2023: 4.6%FY 2024: 0.1%FY 2025: 2.3%
FY 2016 5y median 3.0% FY 2025
ROA -1.1%
FY 2016: 4.6%FY 2017: 4.7%FY 2018: 4.8%FY 2019: 4.9%FY 2020: 5.0%FY 2021: 5.3%FY 2022: 2.1%FY 2023: 3.5%FY 2024: 0.2%FY 2025: -1.1%
FY 2016 5y median 2.1% FY 2025

Growth (YoY)

Revenue -10.7%
FY 2016: 76.1%FY 2017: 27.6%FY 2018: 35.0%FY 2019: 27.2%FY 2020: 3.4%FY 2021: 28.7%FY 2022: -24.9%FY 2023: 26.7%FY 2024: -8.9%FY 2025: -10.7%
FY 2016 FY 2025
Operating Income 84.9%
FY 2016: 89.9%FY 2017: 24.5%FY 2018: 20.7%FY 2019: 14.1%FY 2020: 1.2%FY 2021: 10.5%FY 2022: -61.3%FY 2023: 34.1%FY 2024: -76.5%FY 2025: 84.9%
FY 2016 FY 2025
EPS (diluted) -734.6%
FY 2016: 29.4%FY 2017: 18.2%FY 2018: 15.4%FY 2019: 6.7%FY 2020: 3.1%FY 2021: 15.2%FY 2022: -60.5%FY 2023: 73.3%FY 2024: -95.9%FY 2025: -734.6%
FY 2016 FY 2025
Free Cash Flow -5.5%
FY 2016: 341.8%FY 2017: -51.0%FY 2018: -111.9%FY 2019: 669.9%FY 2020: -348.7%FY 2021: 92.1%FY 2022: 796.2%FY 2023: 20.4%FY 2024: 204.5%FY 2025: -5.5%
FY 2016 FY 2025

Financial Health

Current Ratio 2.3×
FY 2016: 2.3×FY 2017: 2.4×FY 2018: 1.7×FY 2019: 1.4×FY 2020: 2.0×FY 2021: 2.1×FY 2022: 1.8×FY 2023: 2.1×FY 2024: 2.4×FY 2025: 2.3×
FY 2016 5y median 2.1× FY 2025
Quick Ratio 1.8×
FY 2016: 1.8×FY 2017: 1.7×FY 2018: 1.2×FY 2019: 1.0×FY 2020: 1.3×FY 2021: 1.5×FY 2022: 1.2×FY 2023: 1.5×FY 2024: 1.8×FY 2025: 1.8×
FY 2016 5y median 1.5× FY 2025
Debt / Equity 0.1×
FY 2016: 0.3×FY 2017: 0.4×FY 2018: 0.4×FY 2019: 0.3×FY 2020: 0.3×FY 2021: 0.3×FY 2022: 0.3×FY 2023: 0.2×FY 2024: 0.2×FY 2025: 0.1×
FY 2016 5y median 0.2× FY 2025
Net Debt / EBITDA -1.1×
FY 2016: 1.0×FY 2017: 0.3×FY 2018: 0.1×FY 2019: 0.1×FY 2020: 0.6×FY 2021: 0.6×FY 2022: 0.9×FY 2023: 0.8×FY 2024: 0.1×FY 2025: -1.1×
FY 2016 5y median 0.6× FY 2025
Interest Coverage 6.4×
FY 2016: 19.5×FY 2017: 8.1×FY 2018: 7.4×FY 2019: 8.2×FY 2020: 10.2×FY 2021: 12.4×FY 2022: 4.8×FY 2023: 7.2×FY 2024: 1.4×FY 2025: 6.4×
FY 2016 5y median 6.4× FY 2025

Dividends

Dividend Yield 4.1%
FY 2016: 1.7%FY 2017: 2.3%FY 2018: 3.1%FY 2019: 3.0%FY 2020: 1.4%FY 2021: 1.9%FY 2022: 1.8%FY 2023: 1.6%FY 2024: 0.0%FY 2025: 4.1%
FY 2016 5y median 1.8% FY 2025
Payout Ratio -115.9%
FY 2016: 25.4%FY 2017: 27.0%FY 2018: 33.3%FY 2019: 31.6%FY 2020: 13.0%FY 2021: 14.3%FY 2022: 41.1%FY 2023: 18.7%FY 2024: 0.0%FY 2025: -115.9%
FY 2016 5y median 14.3% FY 2025

Annual · latest fiscal year ends 2025-12-31